Clinical Trial Update: Fixed-Dose Trial in Early Parkinson's Disease (PD) [Phase 3]

View source ↗

Summary

AbbVie-sponsored Phase 3 fixed-dose trial in early Parkinson disease has completed and posted results. This document provides an update on the trial status and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: AbbVie | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-07-28